Literature DB >> 24459900

[Screening of urinary biomarkers in patients with type 2 diabetes mellitus].

Han Fu1, Xiaoli Liu1, Wei Yu1, Lijia Zhu1, Dan Zheng1, Jun Wang1.   

Abstract

OBJECTIVE: To screen the biomarkers of the middle-aged type 2 diabetes (T2DM) in urine based on metabolomics.
METHODS: First, both the metabolite profiles of morning urine sample in T2DM and control group were obtained by liquid chromatography-mass spectrometry (LC-MS). Second, an automated compound (feature) extraction algorithm was employed for processing background subtracted single MS data. Then principal component analysis (PCA) and t-Test analysis was followed after preprocessing on the extractive data. Third, identifying the potential biomarkers that show significant difference between the two groups by searching the database online and comparing the results of MS/MS experiments to those available in literature and those standards.
RESULTS: Three endogenous metabolites, among which tryptophan, kynurenic acid, and shown down-regulation while kynurenine shown up-regulation in T2DM, significantly differentiate between T2DM and control group.
CONCLUSION: Tryptophan, kynurenic acid and kynurenine may be considered as the potentail biomarkers related to T2DM.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24459900

Source DB:  PubMed          Journal:  Wei Sheng Yan Jiu        ISSN: 1000-8020


  2 in total

1.  The kynurenine:tryptophan ratio as a predictor of incident type 2 diabetes mellitus in individuals with coronary artery disease.

Authors:  Eirik W Rebnord; Elin Strand; Øivind Midttun; Gard F T Svingen; Monika H E Christensen; Per M Ueland; Gunnar Mellgren; Pål R Njølstad; Grethe S Tell; Ottar K Nygård; Eva R Pedersen
Journal:  Diabetologia       Date:  2017-06-13       Impact factor: 10.122

Review 2.  Kynurenine pathway in kidney diseases.

Authors:  Izabela Zakrocka; Wojciech Załuska
Journal:  Pharmacol Rep       Date:  2021-10-06       Impact factor: 3.919

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.